John Michael Middlecott Banham - Director, Cyclacel Pharmaceuticals, Inc
As of June 29, 2020
John Michael Middlecott Banham Net Worth
- Net worth is estimated to be at least $1.03M
- Owns at least 36,847 units of Cyclacel Pharmaceuticals, Inc stock
John Michael Middlecott Banham Trading
- Largest purchase of shares was 3,500 units , worth over $20.51K on September 8, 2006
- In total has made about 16 transactions over 14 years
- Usually trades in May, with the busiest year in 2006
John Michael Middlecott Banham
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
John Michael Middlecott Banham Mailing Address
- Mailing address is C/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ 07922 NJ
Cyclacel Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 12 units sold on December 2, 2021 by Sam L Barker worth over $42.86
- In the last 15 years, insiders at Cyclacel Pharmaceuticals, Inc sold an estimated value of $7.67M and bought an estimated value of $14.98M
- The most active traders are Spiro Rombotis, President and CEO, Morgan Stanley, and David C. U'Prichard, Director
- Insider trading is most common in May, with the busiest year in 2008
Cyclacel Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |